Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Advertising workflow software company Mediaocean and business design partner IBM iX launched a blockchain consortium for the digital media supply chain, the companies announced June 19.
McKesson, a medical supply and pharmaceutical distributor, will close its facility in Rocky Hill, Conn., resulting in job losses for 105 people, according to a Fox 61 report.
The FDA granted a De Novo request for DreaMed Diabetes' artificial intelligence-based decision support software Advisor Pro, the Israeli diabetes management solutions developer confirmed June 18.
Las Vegas, NV and Louisville, CO - Tuesday, May 08, 2018- Global Healthcare Exchange, LLC (GHX) announced the GHXcellence Award winners at the 2018 GHX Healthcare Supply Chain Summit awards ceremony today in Las Vegas.
Staff
It happens more often than you might think: a hospital lab technician overnights a mission-critical package not across the country—or even across town—but across campus. Imagine the expense and inefficiency of overnighting that single package. Then multiply it by hundreds…
Melissa Laber, SVP of OptiFreight® Logistics, a Cardinal Health company
Here are the four latest drugs or medical devices approved by the FDA since June 8:
Flex Pharma, a biotechnology company based in Boston, will lay off 60 percent of its workforce by the end of June and is considering a sale or merger to remain afloat, after ending a midstage trial of its lead drug…
The majority of U.S. consumers — 64 percent — indicated they believe product recalls are "less about protecting consumers and more about government regulations," according to a survey by product recall management company Stericycle Expert Solutions.
Johnson & Johnson will sell its LifeScan diabetes unit to the private equity firm Platinum Equity for $2.1 billion, reports CNBC.
The American Medical Association is seeking the help of the federal government and drugmakers in fighting what it calls the public health crisis of drug shortages.